title: [Manifestations, treatment and prognosis in acute leukemia].
abstract: One hundred fifty one patients were studied--with acute lymphoblast leukosis (ALL) and acute non-lymphoblast (myelogenic) leukosis (ANLL). The disease had a fulminant course in 118 of the patients studied (21.8%). In 73 patients, out of 118 studied, no treatment effect was obtained (61.9%) and the rest 45 patients developed a complete remission (38.1%). In 10 of the patients with no treatment effect, a partial remission was obtained (8.4%). The remission is more frequent in case of ALL. The younger age, at present, remains the most essential prognostic factor. Partial initial leukose infiltration of the bone marrow was found in some of the patients. The bone marrow aplasia is not an obligatory phase of remission. The latter could develop by a gradual restoration of the normal hematopoiesis. The existence of stages with inducing of leukosis processes is possible that follow the reverse way in remission development. Hemorrhages are the most frequent complications in forms with fulminant course, and the infections--in the rest of the patients.
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000175:diagnosis / Q000188:drug therapy*; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011379:Prognosis
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Proiavi, lechenie i prognoza pri ostrata levkoza.